Related Experiment Video
Updated: Mar 29, 2026

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
Oscar G W Wong1, Annie N Y Cheung1
1a Department of Pathology , The University of Hong Kong , Hong Kong Special Administrative Region , People's Republic of China.
Introduction:
Targeting cancer stem cells can be a more effective approach to treat cancer. NANOG is one of the key factors for maintaining the self-renewal ability and pluripotency of stem cells, including cancer stem cells. Overexpression of NANOG has been observed in various human malignancies. Several reports have suggested that NANOG contributes to carcinogenesis by initiating and preserving cancer stem cells. It is obvious that NANOG is also involved in establishing other hallmarks of cancer such as uncontrolled cell growth, chemoresistance, metastasis, and immune evasion.
Areas Covered:
This review will discuss the molecular properties and oncogenic roles of NANOG. The idea of using agents that inhibit the transcription factor to treat cancer is presented. Interfering with NANOG-mediated transcriptions using small interfering RNA, transcription factor decoy, genome editing, and small-molecule inhibitors may provide novel strategies to target cancer stem cells.
Expert Opinion:
As a pivotal controller in cancer stem cell maintenance and a positive regulator of various oncogenic pathways, NANOG may be an important target for cancer therapy. However, as a transcription factor, it is inherently difficult to target by pharmacological means. Novel approaches need to be explored before the inhibition of NANOG can be applied in a clinical setting.
Insights
NANOG is a key factor in cancer stem cell self-renewal and cancer progression. Inhibiting NANOG offers a potential therapeutic strategy, but challenges remain in targeting this transcription factor effectively for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- NANOG is crucial for stem cell self-renewal and pluripotency, including in cancer stem cells.
- Overexpressed NANOG drives carcinogenesis, promoting hallmarks of cancer like uncontrolled growth, chemoresistance, metastasis, and immune evasion.
Purpose of the Study:
- To review the molecular properties and oncogenic roles of NANOG.
- To present NANOG inhibition as a potential therapeutic strategy against cancer stem cells.
Main Methods:
- Discussion of NANOG's molecular properties and oncogenic functions.
- Exploration of strategies to inhibit NANOG, including small interfering RNA, transcription factor decoys, genome editing, and small-molecule inhibitors.
Main Results:
- NANOG plays a pivotal role in maintaining cancer stem cells and regulating oncogenic pathways.
- Targeting NANOG presents a promising avenue for novel cancer therapies.
Conclusions:
- NANOG is a significant target for cancer therapy due to its role in cancer stem cell maintenance.
- Pharmacological targeting of transcription factors like NANOG is challenging, necessitating further research for clinical application.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Induced Pluripotent Stem Cells
Somatic...
Methods of Nuclear Reprogramming
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes

